14.10.2013

Anaferon for children has been recognized by European Respiratory Society as an effective drug for the treatment of recurring viral upper respiratory infections in children with bronchial asthma

Annual Congress of European Respiratory Society 2013 (ERS 2013) held on September 7-11, 2013 in Barcelona, presented the results of a randomized double-blind placebo-controlled study of efficacy of Anaferon for children in prevention and therapy of recurring viral upper respiratory infections in children with bronchial asthma.

Head of Department of pediatrics of Novosibirsk Medical University, professor Kondyurina E.G. presented the data verifying that Anaferon for children applied for prevention and therapy of recurring viral upper respiratory infections in children with bronchial asthma reduces duration and severity of the infection, significantly decreases the incidence of recurrent viral URIs and prevents virus-induced exacerbations of bronchial asthma.

https://www.ersnetsecure.org/public/prg_congres.abstract?ww_i_presentation=64257

https://www.ersnetsecure.org/public/prg_congres.abstract?ww_i_presentation=64258